title: Limited Value of the Multi-Biomarker Disease Activity Assay Compared to the Routine Assessment of Patient Index Data 3 (RAPID3) Score in the Prognosis of Important Clinical Outcomes in Rheumatoid Arthritis: Comment on the Article by Fleischmann et al and Accompanying Editorial by Davis.
authors.affiliation: Rush University Medical Center, Chicago, IL.
authors.forename: Theodore
authors.initials: T
authors.lastname: Pincus
authors.affiliation: Rush University Medical Center, Chicago, IL.
authors.forename: Joel A
authors.initials: JA
authors.lastname: Block
authors.affiliation: Hospital for Joint Diseases, New York University, New York, NY.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Yazici
authors.affiliation: Taylor Hospital, Ridley Park, PA.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Bergman
authors.affiliation: Jyvalkyla Central Hospital, Jyvaskyla, Finland.
authors.forename: Tuulikki
authors.initials: T
authors.lastname: Sokka
mesh_terms: D000069594:Abatacept; D000068879:Adalimumab; D001172:Arthritis, Rheumatoid; D015415:Biomarkers; D006801:Humans; D011379:Prognosis
chemical_list: D015415:Biomarkers; D000069594:Abatacept; D000068879:Adalimumab